Dr. Rahul Buggaveeti is a distinguished Head & Neck Oncology surgeon based at Apollo Health City, Jubilee Hills, Hyderabad. With over 11+ years of experience in the medical field, he has dedicated his career to providing exceptional surgical care to patients dealing with complex head and neck cancers, thyroid disorders, and salivary gland conditions.
Dr. Buggaveeti is proficient in multi-site surgeries and offers effective communication with patients facing a diverse range of conditions. He is known for his patient-centric approach, emphasizing the importance of understanding each patient's unique needs and individualized treatment plans. He ensures that patients receive precise diagnoses and comprehensive treatments, blending advanced surgical techniques with compassionate care.
Dedicated to staying updated with advancements in his field, Dr. Rahul Buggaveeti actively collaborates with multidisciplinary professionals to provide comprehensive care. He is committed to improving health outcomes by conducting clinical research and presenting at various national and international conferences, contributing valuable insights to the field of head and neck oncology.
- Surgical Oncology
- Oral Cancer Surgery
- Laryngeal Cancer Surgery
- Hypopharyngeal Cancer Surgery
- Neck Dissection
- Thyroid Cancer Surgery
- Thyroid Surgery
- Salivary Gland Surgery
- Salivary Gland Tumor Removal
- Sentinel Lymph Node Biopsy
- Head & Neck Tumor Surgery
- Composite Resection
- Oropharyngeal Cancer Surgery
- MS (ENT)
- MCh (Head and neck surgical oncology)
- MBBS
Dr. Rahul Buggaveeti began his career as a Registrar at the Department of Head & Neck Oncology at Apollo Cancer Hospital. He subsequently completed a fellowship in Robotic Head and Neck Oncology (Yonsie,Korea). He then worked as a Consultant in head and neck surgical oncology at Apollo Health City, Jubilee Hills, Hyderabad, where he continues to practice. He also holds a Foundation membership in Head & Neck Oncology, Bangalore.
- Apollo Health City, Jubilee Hills
- Prior chemo radiotherapy and pathological perineural invasion predict the survival outcome of savage surgery in head and neck squamous cell carcinoma
- Parathyroid Hormone as a marker for predicting the severity of hypocalcaemia following parathyroidectomy.
- Foundation of Head & Neck Oncology, Bangalore
From your first enquiry to recovery back home — we manage every detail so you can focus on getting better.
Join 5,000+ patients from 40+ countries who chose world-class care at a fraction of the cost.
